To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)
- Registration Number
- NCT00276484
- Lead Sponsor
- Organon and Co
- Brief Summary
To Evaluate and Compare the Efficacy and Safety of Ezetimibe Plus Atorvastatin Versus Atorvastatin in Hypercholesterolemic Patients at High Risk for Coronary Heart Disease Not Adequately Controlled on Atorvastatin 40 mg.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 579
- Patient with LDL-C >70 mg/dL & on a stable dose of atorvastatin 40 mg
- Pregnant or lactating women or intending to become pregnant
- Patient with sensitivity or intolerance to ezetimibe or atorvastatin
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 ezetimibe Atorvastatin 40 mg + ezetimibe 10 mg 1 atorvastatin Atorvastatin 80 mg 2 atorvastatin Atorvastatin 40 mg + ezetimibe 10 mg
- Primary Outcome Measures
Name Time Method Percent Change From Baseline to Week 6 in Low-Density Lipoprotein (LDL)-C Baseline and 6 weeks Percent Change in LDL-C = \[(week 6 value - baseline value)/baseline value\]\*100%
- Secondary Outcome Measures
Name Time Method Percent Change From Baseline to Week 6 in Triglycerides (TG) Baseline and 6 Weeks Percent Change in TG = \[(week 6 value - baseline value)/baseline value\]\*100%
Number of Patients Who Attained Target Low-Density Lipoprotein Cholesterol (LDL-C) <70 mg/dL at Week 6 6 Weeks Percent Change From Baseline to Week 6 in High-Density Lipoprotein Cholesterol (HDL-C) Baseline and 6 weeks Percent Change in HDL-C = \[(week 6 value - baseline value)/baseline value\]\*100%
Percent Change From Baseline to Week 6 in Non-High-Density Lipoprotein Cholesterol (Non-HDL-C) Baseline and 6 Weeks Percent Change in Non-HDL-C = \[(week 6 value - baseline value)/baseline value\]\*100%
Percent Change From Baseline to Week 6 in Total-Cholesterol Baseline and 6 Weeks Percent Change in Total-C = \[(week 6 value - baseline value)/baseline value\]\*100%
Percent Change From Baseline to Week 6 in Apolipoprotein B (Apo B) Baseline and 6 Weeks Percent Change in Apo B = \[(week 6 value - baseline value)/baseline value\]\*100%
Percent Change From Baseline to Week 6 in Low-Density Lipoprotein-Cholesterol:High-Density Lipoprotein-Cholesterol (LDL-C:HDL-C) Ratio Baseline and 6 Weeks Percent Change in LDL-C:HDL-C Ratio = \[(week 6 ratio - baseline ratio)/baseline ratio\]\*100%
Percent Change From Baseline to Week 6 in Apolipoprotein A-I (Apo A-I) Baseline and 6 Weeks Percent Change in Apo A-I = \[(week 6 value - baseline value)/baseline value\]\*100%
Percent Change From Baseline to Week 6 in Apolipoprotein B:Apolipoprotein A-I (Apo B:Apo A-I) Ratio Baseline and 6 Weeks Percent Change in Apo B:Apo A-I Ratio = \[(week 6 ratio - baseline ratio)/baseline ratio\]\*100%
Percent Change From Baseline to Week 6 in Total-Cholesterol (TC):High-Density Lipoprotein Cholesterol (HDL-C) Ratio Baseline and 6 Weeks Percent Change in TC:HDL-C Ratio = \[(week 6 ratio - baseline ratio)/baseline ratio\]\*100%
Percent Change From Baseline to Week 6 in Non-High-Density Lipoprotein-Cholesterol:High-Density Lipoprotein-Cholesterol (Non-HDL-C:HDL-C) Ratio Baseline and 6 Weeks Percent Change in non-HDL-C:HDL-C Ratio = \[(week 6 ratio - baseline ratio)/baseline ratio\]\*100%
Percent Change From Baseline to Week 6 in C Reactive Protein (CRP) Baseline and 6 Weeks Percent Change in CRP = \[(week 6 value - baseline value)/baseline value\]\*100%